Lower leg muscle involvement in Duchenne muscular dystrophy: An MR imaging and spectroscopy study

Skeletal Radiology

Volumn 41, Issue 4, 2012, Pages 437-445

  Torriani, Martin ^a   Townsend, Elise ^b   Thomas, Bijoy J ^a   Bredella, Miriam A ^a   Ghomi, Reza H ^a   Tseng, Brian S ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Duchenne muscular dystrophy; Fatty atrophy; MR imaging; MR spectroscopy; Muscle

Indexed keywords

CREATININE; PHOSPHORUS;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL ASSESSMENT; GASTROCNEMIUS MUSCLE; HUMAN; LEG MUSCLE; LIPID ANALYSIS; LIPID STORAGE; LOWER LEG MUSCLE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERONEUS MUSCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SIX MINUTE WALK TEST; SOLEUS MUSCLE; TEN MINUTE WALK TEST; TIBIALIS ANTERIOR MUSCLE; VIGNOS LOWER EXTREMITY FUNCTIONAL RATING; LEG; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

ADOLESCENT; CHILD; HUMANS; LEG; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PROSPECTIVE STUDIES;

EID: 84862279279     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-011-1240-1     Document Type: Article

References (24)

1. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77-93.
2. Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology. 2010;255:899-908.
3. Schreiber A, Smith WL, Ionasescu V, et al. Magnetic resonance imaging of children with Duchenne muscular dystrophy. Pediatr Radiol. 1987;17:495-7. (Pubitemid 17158243)
4. Liu GC, Jong YJ, Chiang CH, Jaw TS. Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology. 1993;186:475-80.
5. Huang Y, Majumdar S, Genant HK, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging. 1994;4:59-64.
6. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol. 2008;190:W8-12.
7. Beenakker EA, Fock JM, Van Tol MJ, et al. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial. Arch Neurol. 2005;62:128-32. (Pubitemid 40105045)
8. Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve. 1996;19:302-10. (Pubitemid 26069360)
9. Sookhoo S, Mackinnon I, Bushby K, Chinnery PF, Birchall D. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol. 2007;62:160-5. (Pubitemid 46024209)
10. Vignos Jr PJ, Spencer Jr GE, Archibald KC. Management of progressive muscular dystrophy in childhood. JAMA. 1963;184:89-96.
11. Gallagher D, Kuznia P, Heshka S, et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr. 2005;81:903-10. (Pubitemid 41725001)
12. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-9. (Pubitemid 23360802)
13. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129:35-43. (Pubitemid 127454051)
14. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117
15. Mayhew JE, Florence JM, Mayhew TP, et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve. 2007;35:36-42. (Pubitemid 46052646)
16. Cros D, Harnden P, Pellissier JF, Serratrice G. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol. 1989;236:43-7. (Pubitemid 19113123)
17. Jones DA, Round JM, Edwards RH, Grindwood SR, Tofts PS. Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. J Neurol Sci. 1983;60:307-22. (Pubitemid 13071673)
18. Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol. 2005;34:140-8. (Pubitemid 40305454)
19. Arai Y, Osawa M, Fukuyama Y. Muscle CT scans in preclinical cases of Duchenne and Becker muscular dystrophy. Brain Dev. 1995;17:95-103.
20. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010;42:966-74.
21. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci. 1993;116:201-6. (Pubitemid 23176857)
22. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology. 1987;37:165-9.
23. Hsieh TJ, Jaw TS, Chuang HY, Jong YJ, Liu GC, Li CW. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2009;33:150-4.
24. Ikehira H, Nishikawa S, Matsumura K, Hasegawa T, Arimizu N, Tateno Y. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy. Radiat Med. 1995;13:63-5.